Eptacog alfa pegol (activated)

DB11661InvestigationalProtein Based Therapies

Eptacog alfa pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With...

Mechanism: Pharmacologically active on Coagulation factor VII
Curator reviewed
Also known as: Activated Recombinant Human Factor VII, Long Acting

Resolves to

Compound

UNII3Q26I70P3ICAS944130-77-2

Targets

P08709F7

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

36Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Eptacog alfa pegol (activated), and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account